Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer
Condition: Hormone Receptor Positive HER-2 Negative Breast Cancer Intervention: Sponsors: University Hospital Tuebingen; University Hospital Ulm; University Hospital Freiburg Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials